Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Fractional Flow Reserve
77%
Coronary Artery Disease
57%
Revascularization
55%
Rapamycin
54%
Myocardial Infarction
49%
Optical Coherence Tomography
41%
Drug-Eluting Stent
32%
ST Segment Elevation Myocardial Infarction
31%
Stenosis
30%
Hazard Ratio
27%
Coronary Angiography
26%
Everolimus
26%
Chronic Total Occlusion
24%
Coronary Artery Bypass Graft
23%
Target Lesion
22%
Percutaneous Aortic Valve Replacement
22%
Stent Thrombosis
21%
Angiography
21%
Heart Muscle Revascularization
21%
Umirolimus
21%
Intravascular Ultrasound
20%
Coronary Artery Obstruction
20%
Coronary Artery
20%
Target Lesion Revascularization
19%
Diabetes Mellitus
18%
Diabetes
18%
Heart Death
18%
Coronary Flow Reserve
18%
Coronary Computed Tomography Angiography
17%
Stenting
16%
Major Adverse Cardiac Event
15%
Computed Tomography Angiography
15%
Zotarolimus
15%
Primary Percutaneous Coronary Intervention
14%
Acute Coronary Syndrome
13%
Diagnostic Performance
13%
Acute Heart Infarction
13%
Diagnosis
12%
Coronary Artery Bypass Surgery
12%
Stable Angina Pectoris
12%
Disease
11%
Hemodynamic
10%
Apoplexy
10%
Positron Emission Tomography
10%
Coronary Circulation
10%
Randomized Clinical Trial
10%
Heart Muscle Ischemia
9%
Atrial Fibrillation
9%
All Cause Mortality
9%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
48%
Rapamycin
37%
Coronary Artery Disease
31%
ST Segment Elevation Myocardial Infarction
27%
Umirolimus
26%
Stent Thrombosis
22%
Heart Death
18%
Chronic Total Occlusion
15%
Major Adverse Cardiac Event
14%
All Cause Mortality
14%
Stenosis
13%
Acute Coronary Syndrome
13%
Everolimus
12%
Coronary Artery Obstruction
11%
Coronary Artery Occlusion
8%
Acute Heart Infarction
8%
Stable Angina Pectoris
8%
Zotarolimus
8%
Combination Therapy
7%
CD34 Antibody
7%
Diabetes Mellitus
6%
Aortic Stenosis
6%
Non ST Segment Elevation Myocardial Infarction
5%
Heart Muscle Ischemia
5%
Noninferiority Trial
5%
Disease
5%
Clinical Trial
5%
Keyphrases
Percutaneous Coronary Intervention
6%
Fractional Flow Reserve
5%